Cargando…

SARS-CoV-2 Infection and Lung Regeneration

The lung is the primary site of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)-induced immunopathology whereby the virus enters the host cells by binding to angiotensin-converting enzyme 2 (ACE2). Sophisticated regeneration and repair programs exist in the lungs to replenish injured ce...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhao, Fuxiaonan, Ma, Qingwen, Yue, Qing, Chen, Huaiyong
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Society for Microbiology 2022
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8809385/ https://www.ncbi.nlm.nih.gov/pubmed/35107300 http://dx.doi.org/10.1128/cmr.00188-21

Ejemplares similares

Impaired lung regeneration after SARS‐CoV‐2 infection
por: Shao, Hongxia, et al.
Publicado: (2020)

Organoid technology and lung injury mouse models evaluating effects of hydroxychloroquine on lung epithelial regeneration
por: Zhao, Fuxiaonan, et al.
Publicado: (2022)

Organoid technology demonstrates effects of potential drugs for COVID‐19 on the lung regeneration
por: Wang, Jianhai, et al.
Publicado: (2020)

Plasma metabolomic characterization of SARS-CoV-2 Omicron infection
por: Li, Xue, et al.
Publicado: (2023)

SARS-CoV-2 and the Nucleus
por: Chen, Mengqi, et al.
Publicado: (2022)

Cellular metabolic basis of altered immunity in the lungs of patients with COVID-19
por: Li, Shuangyan, et al.
Publicado: (2022)

Lung Organoids as Model to Study SARS-CoV-2 Infection
por: Peng, Li, et al.
Publicado: (2022)

SARS-CoV, MERS-CoV and SARS-CoV-2 infections in pregnancy and fetal development
por: de Souza Silva, Guilherme Antonio, et al.
Publicado: (2020)

Endomembrane remodeling in SARS-CoV-2 infection
por: Chen, Di, et al.
Publicado: (2022)

Comparison of the COVID-2019 (SARS-CoV-2) pathogenesis with SARS-CoV and MERS-CoV infections
por: Fani, Mona, et al.
Publicado: (2020)

Imaging findings in coronavirus infections: SARS-CoV, MERS-CoV, and SARS-CoV-2
por: Franquet, Tomas, et al.
Publicado: (2020)

Lung regeneration post SARS-CoV-2 infection: is it all about pneumocytes type II?
por: Armando, F., et al.
Publicado: (2023)

Immunological co-ordination between gut and lungs in SARS-CoV-2 infection
por: Ahlawat, Shruti, et al.
Publicado: (2020)

SARS-CoV-2 Infection and Lung Cancer: Potential Therapeutic Modalities
por: Gupta, Ishita, et al.
Publicado: (2020)

Lung microbiota dysbiosis and the implications of SARS-CoV-2 infection in pregnancy
por: Ezechukwu, Henry C., et al.
Publicado: (2021)

The roles of signaling pathways in SARS-CoV-2 infection; lessons learned from SARS-CoV and MERS-CoV
por: Hemmat, Nima, et al.
Publicado: (2021)

SARS-CoV-2 Infection and the Liver
por: Morgan, Katie, et al.
Publicado: (2020)

Inflammasomes and SARS-CoV-2 Infection
por: Kaivola, Juha, et al.
Publicado: (2021)

Neuroimmunoendocrinology of SARS-CoV-2 Infection
por: Bellastella, Giuseppe, et al.
Publicado: (2022)

Immune Responses in SARS-CoV-2, SARS-CoV, and MERS-CoV Infections: A Comparative Review
por: Irani, Soussan
Publicado: (2022)

Gastrointestinal Involvement in SARS-CoV-2 Infection
por: Chen, Tsung-Hsien, et al.
Publicado: (2022)

Comparison of the Characteristics of Cytokine Storm and Immune Response Induced by SARS-CoV, MERS-CoV, and SARS-CoV-2 Infections
por: Liu, Tong, et al.
Publicado: (2021)

Long-Term Health Consequences of SARS-CoV-2: Assumptions Based on SARS-CoV-1 and MERS-CoV Infections
por: Khaswal, Ashutosh, et al.
Publicado: (2022)

Impact of corticosteroid therapy on outcomes of persons with SARS-CoV-2, SARS-CoV, or MERS-CoV infection: a systematic review and meta-analysis
por: Li, Huan, et al.
Publicado: (2020)

Oral Microbiome and SARS-CoV-2: Beware of Lung Co-infection
por: Bao, Lirong, et al.
Publicado: (2020)

SARS-CoV-2 infection in children
por: Çokuğraş, Haluk, et al.
Publicado: (2020)

Pharmacotherapeutics of SARS-CoV-2 Infections
por: Kevadiya, Bhavesh D., et al.
Publicado: (2021)

The Immunopathobiology of SARS-CoV-2 Infection
por: Patel, Milankumar, et al.
Publicado: (2021)

Establishment of human distal lung organoids for SARS-CoV-2 infection
por: Wang, Ting, et al.
Publicado: (2021)

Co-infection associated with SARS-CoV-2 and their management
por: Chavda, Vivek P, et al.
Publicado: (2023)

Host factors facilitating SARS‐CoV‐2 virus infection and replication in the lungs
por: Boutin, Sébastien, et al.
Publicado: (2021)

Drug repurposing against SARS-CoV-1, SARS-CoV-2 and MERS-CoV
por: Aherfi, Sarah, et al.
Publicado: (2021)

An Updated Review on SARS-CoV-2 Infection in Animals
por: Cui, Shujuan, et al.
Publicado: (2022)

Analysis of the susceptibility of lung cancer patients to SARS-CoV-2 infection
por: Kong, Qi, et al.
Publicado: (2020)

Comparative highlights on MERS-CoV, SARS-CoV-1, SARS-CoV-2, and NEO-CoV
por: Goyal, Rajat, et al.
Publicado: (2022)

The immunology of SARS-CoV-2 infections and vaccines
por: Grigoryan, Lilit, et al.
Publicado: (2020)

SARS-CoV-2 infection in pediatric population
por: Manti, Sara, et al.
Publicado: (2020)

Endothelial Dysfunction in SARS-CoV-2 Infection
por: Nappi, Francesco, et al.
Publicado: (2022)

Hematopoietic responses to SARS-CoV-2 infection
por: Elahi, Shokrollah
Publicado: (2022)

T cells in SARS-CoV-2 infection and vaccination
por: Young, Arthur
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_d24n0lm24551fa34fusb4ribsq